60 related articles for article (PubMed ID: 2152323)
21. Treatment of bleeding esophageal varices with cyanoacrylate and polidocanol, or polidocanol alone: results of a prospective study in an unselected group of patients with cirrhosis of the liver.
Lux G; Retterspitz M; Stabenow-Lohbauer U; Langer M; Altendorf-Hofmann A; Bozkurt T
Endoscopy; 1997 May; 29(4):241-6. PubMed ID: 9255525
[TBL] [Abstract][Full Text] [Related]
22. Ethanolamine oleate for esophageal varices.
Med Lett Drugs Ther; 1989 Nov; 31(804):99-100. PubMed ID: 2682155
[No Abstract] [Full Text] [Related]
23. Long-term risk factors for bleeding after first course of endoscopic injection sclerotherapy: a univariate and multivariate analysis.
Kokawa H; Shijo H; Kubara K; Nakaoka K; Toriya H; Shirai Z; Okazaki M
Am J Gastroenterol; 1993 Aug; 88(8):1206-11. PubMed ID: 8393274
[TBL] [Abstract][Full Text] [Related]
24. Anaphylactic reaction to ethanolamine oleate injection in sclerotherapy of esophageal varices.
Bordas JM; Feu F; Vilella A; Rodés J
Endoscopy; 1989 Jan; 21(1):50. PubMed ID: 2917540
[No Abstract] [Full Text] [Related]
25. [Efficacy of elective endoscopic sclerotherapy of hemorrhage from esophageal varices. 2-year follow-up].
Cabriada J; Orive V; Alzate LF; Arenas JI
Rev Esp Enferm Apar Dig; 1988 Oct; 74(4 Pt 2):429-34. PubMed ID: 3265215
[No Abstract] [Full Text] [Related]
26. [Studies on the damage of the cultured endothelial cells and K-562 cells by sclerosants (ethanolamine oleate, Aethoxysklerol and absolute ethanol) used in the treatment of esophageal varices].
Orikasa K
Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2365-72. PubMed ID: 2593306
[TBL] [Abstract][Full Text] [Related]
27. [38 cases of sclerotherapy of esophageal varices].
Sigiyama K; Li ZL
Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):263-5, 317. PubMed ID: 3876916
[No Abstract] [Full Text] [Related]
28. [Use of sclerotherapy in patients with esophageal varices. Guidelines of the German Society of Digestive and Metabolic Diseases].
Robertz-Vaupel GM; Sauerbruch T
Z Gastroenterol; 1993 Mar; 31(3):221-3. PubMed ID: 8475649
[No Abstract] [Full Text] [Related]
29. Endoscopic sclerotherapy of esophageal varices.
Novis B; Bat L; Pomerantz I; Shemesh E
Isr J Med Sci; 1983 Jan; 19(1):40-4. PubMed ID: 6601090
[No Abstract] [Full Text] [Related]
30. A prospective randomized study comparing the effects of large and small volumes of the sclerosant 5% ethanolamine oleate injected into esophageal varices.
Iso Y; Kitano S; Iwanaga T; Koyanagi N; Sugimachi K
Endoscopy; 1988 Nov; 20(6):285-8. PubMed ID: 3229387
[TBL] [Abstract][Full Text] [Related]
31. Esophageal strictures after endoscopic injection sclerotherapy.
Dolar ME; Boyacioglu AS; Ates KB; Caner ME; Hilmioglu F; Sahin B
Endoscopy; 1994 May; 26(4):370. PubMed ID: 8076576
[No Abstract] [Full Text] [Related]
32. Over-tube technique and intentional removal of the distal mucosa with repeated injections of 5% ethanolamine oleate to sclerose esophageal varices.
Kitano S; Hashizume M; Sugimachi K
Hepatogastroenterology; 1990 Dec; 37(6):569-70. PubMed ID: 2289770
[No Abstract] [Full Text] [Related]
33. Comparison of argon plasma coagulation and paravariceal injection sclerotherapy with 1% polidocanol in mucosa-fibrosing therapy for esophageal varices.
Matsui S; Kudo M; Nakaoka R; Shiomi M; Kawasaki T
J Gastroenterol; 2004; 39(4):397-9. PubMed ID: 15168254
[No Abstract] [Full Text] [Related]
34. Combined ligation and sclerotherapy versus ligation alone for eradication of bleeding esophageal varices: a randomized and prospective trial.
Djurdjevic D; Janosevic S; Dapcevic B; Vukcevic V; Djordjevic D; Svorcan P; Grgov S
Endoscopy; 1999 May; 31(4):286-90. PubMed ID: 10376453
[TBL] [Abstract][Full Text] [Related]
35. Polidocanol may directly activate the contact phase of blood coagulation during sclerotherapy.
Musso R; Longo A; Triolo A; Giustolisi R; Cacciola RR; Cacciola E; Vecchio R; Russo A; Magnano A
Gastrointest Endosc; 1987 Oct; 33(5):400-2. PubMed ID: 3678776
[No Abstract] [Full Text] [Related]
36. Injection sclerotherapy of esophageal varices.
Jorge AD
Endoscopy; 1982 Jul; 14(4):115-8. PubMed ID: 6980114
[TBL] [Abstract][Full Text] [Related]
37. A prospective randomized trial from Turkey comparing octreotide versus injection sclerotherapy in acute variceal bleeding.
Sivri B; Oksuzoglu G; Bayraktar Y; Kayhan B
Hepatogastroenterology; 2000; 47(31):168-73. PubMed ID: 10690604
[TBL] [Abstract][Full Text] [Related]
38. Heart failure as a side effect of polidocanol given for oesophageal variceal sclerosis.
Imperiali G; Terruzzi V; Spotti D; Minoli G
Endoscopy; 1986 Sep; 18(5):207. PubMed ID: 3780593
[No Abstract] [Full Text] [Related]
39. Sclerosants for variceal sclerotherapy: a critical appraisal.
Sarin SK; Kumar A
Am J Gastroenterol; 1990 Jun; 85(6):641-9. PubMed ID: 2191592
[TBL] [Abstract][Full Text] [Related]
40. Sclerotherapy after variceal hemorrhage in noncirrhotic portal fibrosis.
Bhargava DK; Dwivedi M; Dasarathy S; Sundaram KR
Am J Gastroenterol; 1989 Oct; 84(10):1235-8. PubMed ID: 2801673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
